Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Safety of Nabilone in reducing marijuana craving
Randomized double blind trial into the safety and efficacy of Cesemat for the treatment of marijuana use
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cesemat | Experimental |
| |
| Placebo | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cesemat | Drug | 1 mg capsule per day for 21 days |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Safety and tolerability to Nabilone |
| Measure | Description | Time Frame |
|---|---|---|
| Marijuana craving questionnaire |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Shaohua Lu, MD | University of British Columbia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vancouver General Hospital - Psychiatry Outpatient | Vancouver | British Columbia | Canada |
Not provided
| ID | Term |
|---|---|
| D008385 | Marijuana Smoking |
| D002189 | Marijuana Abuse |
| ID | Term |
|---|---|
| D000074609 | Marijuana Use |
| D001519 | Behavior |
| D000073847 | Smoking, Non-Tobacco Products |
| D012907 | Smoking |
Not provided
Not provided
| ID | Term |
|---|---|
| C011941 | nabilone |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D019966 |
| Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |